Welcome8:00 AM to 8:05 AM  | Speaker: Leigh Ann Ross, Pharm.D., FCCP, BCPS
Dean and Professor at Auburn University Harrison College of Pharmacy (AUHCOP)
View Biography |
|
New Educator Award8:05 AM to 8:15 AM  | Award Winner: Taylor D. Steuber, Pharm.D., BCPS
Associate Clinical Professor and Assistant Director, Professional Program
Auburn University Harrison College of Pharmacy
Huntsville, Alabama
View Biography |
|
New Clinical Practitioner Award8:15 AM to 8:25 AM  | Award Winner: Justin R. Arnall, Pharm.D., BCOP
Clinical Coordinator, Hematology, Special Pharmacy Service, Atrium Health, Charlotte, North Carolina
View Biography |
|
New Investigator Award/Lecture — Merging Multiple National Data Sets to Evaluate Health Outcomes Associated with Pharmacologic Approaches to Glycemic Treatment8:25 AM to 8:45 AM
Available for 0.25 hours of CPE credit
Activity Number: 0217-0000-22-215-L04-P
Activity Type: A Knowledge-Based Activity
In this presentation, Dr. Weeda will give a brief overview of her recent work evaluating health outcomes associated with pharmacologic approaches to glycemic treatment. She will discuss her work focused on the association between sulfonylureas and outcomes and findings in this area.  | Award Winner: Erin R. Weeda, Pharm.D., BCPS
Associate Professor, Medical University of South Carolina College of Pharmacy; Research Health Scientist, Ralph H. Johnson VA Medical Center, Charleston, South Carolina
View Biography |
Learning Objectives 1. Summarize guideline recommendations pertinent to sulfonylurea use. 2. Describe the association between sulfonylurea use and health outcomes. |
Education Award8:45 AM to 8:55 AM  | Award Winner: Eric MacLaughlin, Pharm.D., FCCP, BCPS
Professor and Chair, Department of Pharmacy Practice
Texas Tech University Health Sciences Center, Amarillo, Texas
View Biography |
|
Clinical Practice Award8:55 AM to 9:05 AM  | Award Winner: Mitchell Buckley, Pharm.D., FCCP
Clinical Pharmacy Specialist, Banner University Medical Center Phoenix, Phoenix, Arizona
View Biography |
|
Russell R. Miller Award9:05 AM to 9:15 AM  | Award Winner: Kevin W. Garey, Pharm.D., FCCP, BCIDP
Professor and Chair
University of Houston College of Pharmacy
Houston, Texas
View Biography |
|
C. Edwin Webb Professional Advocacy Award9:15 AM to 9:25 AM  | Award Winner: Todd D. Sorensen, Pharm.D., FCCP
Professor and Senior Executive Associate Dean, University of Minnesota;
Executive Director, Alliance for Integrated Medication Management,
Minneapolis, Minnesota
View Biography |
|
Paul F. Parker Medal Award9:25 AM to 9:40 AM  | Award Winner: John Elliott Murphy, III, Pharm.D., FCCP
Professor Emeritus, The University of Arizona R. Ken Coit College of Pharmacy, Tucson, Arizona
View Biography |
|
Break9:40 AM to 9:50 AM |
Outgoing President's Address9:50 AM to 10:10 AM | Speaker: Leigh Ann Ross, Pharm.D., FCCP, BCPS
Dean and Professor at Auburn University Harrison College of Pharmacy (AUHCOP)
View Biography |
|
Incoming President's Address10:10 AM to 10:30 AM  | Speaker: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Pharmacist III - Pediatrics, Betty H. Cameron Women's and Children's Hospital, New Hanover Regional Medical Center, Wilmington, North Carolina
View Biography |
|
Therapeutic Frontiers Lecture — Sepsis is a Metabolic Disease: Evidence from Metabolomics and Pharmacometabolomics10:30 AM to 11:00 AM
Available for 0.50 hours of CPE credit
Activity Number: 0217-0000-22-216-L01-P
Activity Type: A Knowledge-Based Activity
The presentation will focus on new and emerging data that support the metabolic underpinnings of sepsis and how these data can be used to subphenotype sepsis patients, identify new drug target opportunities, and assess drug response.  | Award Winner: Kathleen A. Stringer, Pharm.D., FCCP
Albert B. Prescott Collegiate Professor of Clinical and Translational Pharmacy, University of Michigan College of Pharmacy; Professor, Internal Medicine, Pulmonary and Critical Care Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan
View Biography |
Learning Objectives 1. Discuss sepsis and its impact on human health.
2. Review the science of metabolomics and pharmacometabolomics. 3. Describe how metabolomics can be used to phenotype sepsis and assess response to pharmacotherapy. |
ACCP Foundation11:00 AM to 11:15 AM  | Speaker: Jeffrey R. Bishop, Pharm.D., MS, FCCP, BCPP
Associate Professor, University of Minnesota, Department of Experimental and Clinical Pharmacology, College of Pharmacy,
Minneapolis, Minnesota
View Biography |
|
Pharmacotherapy Publications, Inc: Pharmacotherapy and JACCP11:15 AM to 11:25 AM  | Speaker: James E. Tisdale, Pharm.D., FCCP, BCPS
Professor, Department of Pharmacy Practice, College of Pharmacy, Purdue University, and Adjunct Professor, School of Medicine, Indiana University, Indianapolis, Indiana
View Biography |
|
Recognition of New Fellows11:25 AM to 11:45 AM | Speaker: Leigh Ann Ross, Pharm.D., FCCP, BCPS
Dean and Professor at Auburn University Harrison College of Pharmacy (AUHCOP)
View Biography |
|